David J Larwood

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 10

Top Venues

Viruses

Journal of fungi (Basel, Switzerland)

Antibiotics (Basel, Switzerland)

Antimicrobial agents and chemotherapy

Valley Fever Solutions

University of California San Francisco (MSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Valley Fever Solutions Oct 03 2007

United States

CEO

Verisity Apr 10 2000 - May 07 2005

United States

VP, General Counsel

FormFactor Aug 18 1997 - Apr 07 2000

United States

VP intellectual Property

Apple Inc Sep 15 1994 - Aug 15 1997

United States

Sr. Manager, Intellectual Property :: Legal

Education History

University of California San Francisco Aug 15 1979 - Aug 15 1983

United States

MSC :: Med and Pharmaceutical Chemistry

California Institute of Technology Sep 10 1970 - Jun 15 1974

United States

BSC

Publications

David J Larwood, David A Stevens
Antifungal Activity of Brilacidin, a Nonpeptide Host Defense Molecule. Antibiotics (Basel, Switzerland) 13 (5) (2024)
David J Larwood, David A Stevens
Antifungal Activity of Brilacidin, a Nonpeptide Host Defense Molecule. Antibiotics (Basel, Switzerland) 13 (5) (2024)
Gabriele Sass, Ioly Kotta-Loizou, Marife Martinez, David J Larwood, David A Stevens
Polymycovirus Infection Sensitizes Aspergillus fumigatus for Antifungal Effects of Nikkomycin Z. Viruses 15 (1) (2023)
Gabriele Sass, David J Larwood, David A Stevens
Synergy In Vitro of Nikkomycin Z with Azole Against the Invasive Form of Candida albicans. Mycopathologia (2023)
Gabriele Sass, Ioly Kotta-Loizou, Marife Martinez, David J Larwood, David A Stevens
Polymycovirus Infection Sensitizes Aspergillus fumigatus for Antifungal Effects of Nikkomycin Z. Viruses 15 (1) (2023)
Gabriele Sass, Ioly Kotta-Loizou, Marife Martinez, David J Larwood, David A Stevens
Polymycovirus Infection Sensitizes Aspergillus fumigatus for Antifungal Effects of Nikkomycin Z. Viruses 15 (1) (2023)
Gabriele Sass, Ioly Kotta-Loizou, Marife Martinez, David J Larwood, David A Stevens
Polymycovirus Infection Sensitizes Aspergillus fumigatus for Antifungal Effects of Nikkomycin Z. Viruses 15 (1) (2023)
Vanice Rodrigues Poester, Lívia Silveira Munhoz, Jéssica Louise Benelli, Aryse Martins Melo, Abdullah M S Al-Hatmi, David J Larwood, Marife Martinez, David A Stevens, Melissa Orzechowski Xavier
Initial Results of the International Efforts in Screening New Agents against Candida auris . Journal of fungi (Basel, Switzerland) 8 (8) (2022)
Gabriele Sass, David J Larwood, Marife Martinez, Paulami Chatterjee, Melissa O Xavier, David A Stevens
Nikkomycin Z against Disseminated Coccidioidomycosis in a Murine Model of Sustained-Release Dosing. Antimicrobial agents and chemotherapy 65 (10) (2021)
David J Larwood
Nikkomycin Z-Ready to Meet the Promise? Journal of fungi (Basel, Switzerland) 6 (4) (2020)

David J Larwood.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

David J Larwood